A novel comprehensive cancer genome profiling for non‐metastatic prostate cancer: study protocol with <scp>FPG500</scp> to detect actionable alterations representative of progressive disease
The study is non-profit, ethically approved (Lazio Area 3, identifier: 7618), and registered at ClinicalTrials.gov (NCT06875297).
Authors
- Enrico Panio (ORCID: https://orcid.org/0000-0001-6332-9004)
- Chiara Ciccarese (ORCID: https://orcid.org/0000-0002-3283-4339)
- Marzia Del Re (ORCID: https://orcid.org/0000-0001-7343-6161)
- Bernardo Rocco (ORCID: https://orcid.org/0000-0002-9135-0035)
- Márcio Covas Moschovas (ORCID: https://orcid.org/0000-0002-3290-7323)
- Simone Assumma
- Angelo Totaro (ORCID: https://orcid.org/0000-0001-6641-6154)
- Tina Pasciuto (ORCID: https://orcid.org/0000-0003-2959-8571)
- Roberto Iacovelli (ORCID: https://orcid.org/0000-0002-1750-2117)
- Filippo Gavi (ORCID: https://orcid.org/0000-0001-9994-4316)
- Maria Chiara Sighinolfi (ORCID: https://orcid.org/0000-0001-7211-0485)
- Camilla Nero (ORCID: https://orcid.org/0000-0002-4442-4046)
- Luca Tagliaferri (ORCID: https://orcid.org/0000-0003-2308-0982)
- Vipul Patel (ORCID: https://orcid.org/0000-0002-8802-9734)
- Giuseppe Pallotta (ORCID: https://orcid.org/0009-0003-9963-3499)
- Ela Patel
- Antonio Gabarrini
- Simona Presutti
- Francesco Pinto (ORCID: https://orcid.org/0000-0003-1937-9957)
Institutions
- University of Central Florida (US)
- Agostino Gemelli University Polyclinic (IT)
- AdventHealth Celebration (US)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-10-10
- DOI
- https://doi.org/10.1111/bju.70019
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00